comparemela.com

Latest Breaking News On - Gesua sive salvadori - Page 9 : comparemela.com

Clearstead Trust LLC Cuts Stock Holdings in Abbott Laboratories (NYSE:ABT)

Clearstead Trust LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,267 shares of the healthcare product maker’s stock after selling 95 shares during the period. Clearstead Trust LLC’s […]

Summit Global Investments Boosts Holdings in Abbott Laboratories (NYSE:ABT)

Summit Global Investments Boosts Holdings in Abbott Laboratories (NYSE:ABT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

ARS Wealth Advisors Group LLC Purchases 876 Shares of Abbott Laboratories (NYSE:ABT)

ARS Wealth Advisors Group LLC raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 21.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,002 shares of the healthcare product maker’s stock after buying an additional 876 shares during […]

One Charles Private Wealth Services LLC Sells 585 Shares of Abbott Laboratories (NYSE:ABT)

One Charles Private Wealth Services LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,757 shares of the healthcare product maker’s stock after selling 585 shares during the period. […]

Sapient Capital LLC Makes New $11 16 Million Investment in Abbott Laboratories (NYSE:ABT)

Sapient Capital LLC bought a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 101,429 shares of the healthcare product maker’s stock, valued at approximately $11,164,000. Other hedge funds and other institutional investors have also made […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.